Zobrazeno 1 - 2
of 2
pro vyhledávání: '"MESH: Interferon beta-1b"'
Autor:
Antonios Bayas, Kp Wandinger, Sten Fredrikson, Cyrille B. Confavreux, B. C. Kieseier, Ludwig Kappos, Mathias Buttmann, Jordi Río, J. De Keyser, David Brassat, Jens Kuhle, Giulio Disanto, Chris H. Polman, M Ecsedi, M. Frontoni, M Hardmeier, Michael Hutchinson, Markus Färkkilä, M. P. Amato, K Baum, T. Kümpfel, Claude Stolz, K Gugleta, M D’hooghe, E Roullet, Bruno Brochet, Karl Vass, Carmen Lienert, Gilles Edan
Publikováno v:
Kuhle, J, Hardmeier, M, Disanto, G, Gugleta, K, Ecsedi, M, Lienert, C, Amato, M P, Baum, K, Buttmann, M, Bayas, A, Brassat, D, Brochet, B, Confavreux, C, Edan, G, Färkkilä, M, Fredrikson, S, Frontoni, M, D'Hooghe, M, Hutchinson, M, De Keyser, J, Kieseier, B C, Kümpfel, T, Rio, J, Polman, C, Roullet, E, Stolz, C, Vass, K, Wandinger, K P & Kappos, L 2016, ' A 10-year follow-up of the European multicenter trial of interferon β-1b in secondary-progressive multiple sclerosis ', Multiple Sclerosis, vol. 22, no. 4, pp. 533-543 . https://doi.org/10.1177/1352458515594440
Multiple Sclerosis Journal
Multiple Sclerosis Journal, 2015, 22 (4), pp.533-43. ⟨10.1177/1352458515594440⟩
Multiple sclerosis (Houndmills Basingstoke England)
Multiple sclerosis journal, 22(4), 533-543. SAGE Publications Inc.
Multiple Sclerosis Journal, SAGE Publications, 2015, 22 (4), pp.533-43. ⟨10.1177/1352458515594440⟩
Multiple Sclerosis, 22(4), 533-543. SAGE Publications Ltd
Multiple Sclerosis Journal
Multiple Sclerosis Journal, 2015, 22 (4), pp.533-43. ⟨10.1177/1352458515594440⟩
Multiple sclerosis (Houndmills Basingstoke England)
Multiple sclerosis journal, 22(4), 533-543. SAGE Publications Inc.
Multiple Sclerosis Journal, SAGE Publications, 2015, 22 (4), pp.533-43. ⟨10.1177/1352458515594440⟩
Multiple Sclerosis, 22(4), 533-543. SAGE Publications Ltd
Objectives: To explore long-term effects of treatment and prognostic relevance of variables assessed at baseline and during the European secondary progressive multiple sclerosis (SPMS) trial of interferon beta 1b (IFNB-1b). Methods: We assessed 362 p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::63fb9a32cb72691d91e7b2892c77b3f0
https://doi.org/10.1177/1352458515594440
https://doi.org/10.1177/1352458515594440
Autor:
Kappos, Ludwig, Edan, Gilles, Freedman, Mark S., Montalbán, Xavier, Hartung, Hans-Peter, Hemmer, Bernhard, Fox, Edward J., Barkhof, Frederik, Schippling, Sven, Schulze, Andrea, Pleimes, Dirk, Pohl, Christoph, Sandbrink, Rupert, Suarez, Gustavo, Wicklein, Eva-Maria, Csiba, László, Csépány, Tünde
Publikováno v:
ResearcherID
Neurology
Neurology, 2016, 87 (10), pp.978-987. ⟨10.1212/WNL.0000000000003078⟩
Kappos, L, Edan, G, Freedman, M S, Montalbán, X, Hartung, H P, Hemmer, B, Fox, E J, Barkhof, F, Schippling, S, Schulze, A, Pleimes, D, Pohl, C, Sandbrink, R, Suarez, G & Wicklein, E M 2016, ' The 11-year long-term follow-up study from the randomized BENEFIT CIS trial ', Neurology, vol. 87, no. 10, pp. 978-987 . https://doi.org/10.1212/WNL.0000000000003078
Neurology, American Academy of Neurology, 2016, 87 (10), pp.978-987. ⟨10.1212/WNL.0000000000003078⟩
Neurology, American Academy of Neurology, 2016, 87 (10), pp.978-87. ⟨10.1212/WNL.0000000000003078⟩
Neurology, 87(10), 978-987. LIPPINCOTT WILLIAMS & WILKINS
Kappos, Ludwig; Edan, Gilles; Freedman, Mark S; Montalbán, Xavier; Hartung, Hans-Peter; Hemmer, Bernhard; Fox, Edward J; Barkhof, Frederik; Schippling, Sven; Schulze, Andrea; Pleimes, Dirk; Pohl, Christoph; Sandbrink, Rupert; Suarez, Gustavo; Wicklein, Eva-Maria; Mattle, Heinrich (2016). The 11-year long-term follow-up study from the randomized BENEFIT CIS trial. Neurology, 87(10), pp. 978-987. American Academy of Neurology 10.1212/WNL.0000000000003078
Neurology, 87(10), 978-987. Lippincott Williams and Wilkins
Neurology
Neurology, 2016, 87 (10), pp.978-987. ⟨10.1212/WNL.0000000000003078⟩
Kappos, L, Edan, G, Freedman, M S, Montalbán, X, Hartung, H P, Hemmer, B, Fox, E J, Barkhof, F, Schippling, S, Schulze, A, Pleimes, D, Pohl, C, Sandbrink, R, Suarez, G & Wicklein, E M 2016, ' The 11-year long-term follow-up study from the randomized BENEFIT CIS trial ', Neurology, vol. 87, no. 10, pp. 978-987 . https://doi.org/10.1212/WNL.0000000000003078
Neurology, American Academy of Neurology, 2016, 87 (10), pp.978-987. ⟨10.1212/WNL.0000000000003078⟩
Neurology, American Academy of Neurology, 2016, 87 (10), pp.978-87. ⟨10.1212/WNL.0000000000003078⟩
Neurology, 87(10), 978-987. LIPPINCOTT WILLIAMS & WILKINS
Kappos, Ludwig; Edan, Gilles; Freedman, Mark S; Montalbán, Xavier; Hartung, Hans-Peter; Hemmer, Bernhard; Fox, Edward J; Barkhof, Frederik; Schippling, Sven; Schulze, Andrea; Pleimes, Dirk; Pohl, Christoph; Sandbrink, Rupert; Suarez, Gustavo; Wicklein, Eva-Maria; Mattle, Heinrich (2016). The 11-year long-term follow-up study from the randomized BENEFIT CIS trial. Neurology, 87(10), pp. 978-987. American Academy of Neurology 10.1212/WNL.0000000000003078
Neurology, 87(10), 978-987. Lippincott Williams and Wilkins
Objective: To assess outcomes for patients treated with interferon beta-1b immediately after clinicallyisolated syndrome (CIS) or after a short delay.Methods: Participants in BENEFIT (Betaferon/Betaseron in Newly Emerging MS for Initial Treatment)wer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e7a029cf0ab52d97a27be9f238498078
http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000383982200016&KeyUID=WOS:000383982200016
http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000383982200016&KeyUID=WOS:000383982200016
